Press-release for stocks related to covid-19 for orange

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Covid-19 entities : Orange

save search

Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19
Published: 2023-02-21 (Crawled : 22:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M

|

Health Technology

| 14.85% | O: -0.57% H: 0.9% C: 0.16%
covid-19 trial update

5G in Aerospace & Defense Market Research Report by Communication Infrastructure, Core network technology, Operational Frequency, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2023-01-05 (Crawled : 13:20) - prnewswire.com
NOKBF | News | $3.38 -2.55% 1.5K

|

Electronic Technology

| -28.87% | O: -0.84% H: 0.21% C: -0.13%
VZ A | $40.49 0.9% 0.36% 23M

|

| -1.56% | O: 0.17% H: 1.81% C: 1.21%
RTX | $101.56 0.84% 0.11% 6.3M

|

Electronic Technology

| 0.71% | O: -0.57% H: 1.19% C: 0.61%
NOK | News | $3.52 2.03% 0.0% 17M

|

Electronic Technology

| -25.58% | O: -0.21% H: 0.42% C: -0.64%
T | $16.51 1.1% 0.06% 46M

|

| -13.74% | O: 0.0% H: 0.94% C: 0.37%
ERIC | News | $5.1 0.79% 0.78% 19M

|

Electronic Technology

| -15.14% | O: -1.16% H: 1.18% C: 1.01%
CSCO | $48.33 0.46% 0.46% 20M

|

Technology Services

| 1.62% | O: -0.13% H: 0.0% C: -1.28%
ADI | $183.31 -2.28% -2.33% 4.1M

|

Electronic Technology

| 10.52% | O: -0.87% H: 0.7% C: -2.91%
covid-19 research global defense report communication impact market

Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published: 2022-12-09 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -2.47% | O: -0.89% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -49.79% | O: -0.06% H: 2.11% C: -0.06%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -1.13% | O: -0.15% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -49.47% | O: -0.05% H: 0.75% C: -0.83%
covid-19 fda designation candidate vaccine influenza fast track designation

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| 12.43% | O: -0.76% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -1.83% | O: 0.5% H: 0.16% C: 0.16%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -48.25% | O: -0.12% H: 3.36% C: 3.19%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -2.43% | O: -1.32% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -46.62% | O: 0.37% H: 5.31% C: 5.26%
covid-19 fda children vaccine authorization

Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published: 2022-11-16 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 6.71% | O: -1.22% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -45.89% | O: -0.52% H: 1.45% C: 1.11%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 4.56% | O: -2.28% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -47.36% | O: -1.45% H: 2.36% C: 2.31%
covid-19 candidate vaccine study

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
Published: 2022-11-04 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| 18.92% | O: 4.93% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 6.86% | O: -0.02% H: 0.43% C: 0.43%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -44.17% | O: 1.93% H: 0.15% C: -0.53%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 9.12% | O: 2.05% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -40.23% | O: 7.6% H: 0.33% C: -1.27%
covid-19 vaccine response

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Published: 2022-10-12 (Crawled : 15:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -37.98% | O: 0.41% H: 2.49% C: -0.14%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 17.9% | O: 0.76% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -32.96% | O: 3.4% H: 4.91% C: 2.06%
covid-19 fda children vaccine authorization

Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
Published: 2022-08-31 (Crawled : 14:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 16.37% | O: 0.75% H: 1.98% C: 1.98%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -43.29% | O: 0.35% H: 0.6% C: -1.7%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 12.41% | O: 1.1% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -40.98% | O: 0.63% H: 1.42% C: -2.27%
covid-19 fda vaccine granted authorization

Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
Published: 2022-08-23 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| 6.42% | O: -0.87% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 10.96% | O: 1.75% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -46.83% | O: -0.98% H: 0.21% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 12.3% | O: -0.72% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -41.46% | O: 0.13% H: 1.14% C: -0.84%
covid-19 children vaccine

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
Published: 2022-08-22 (Crawled : 15:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 14.44% | O: 1.54% H: 1.57% C: 1.57%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -47.1% | O: 0.12% H: 0.38% C: -0.63%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| 12.6% | O: 0.27% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -41.31% | O: -0.79% H: 2.56% C: 1.06%
covid-19 fda vaccine application authorization

Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
Published: 2022-07-27 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -50.29% | O: -0.69% H: 0.61% C: 0.02%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -8.1% | O: -0.24% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -45.65% | O: -0.13% H: 0.0% C: -2.28%
covid-19 candidate vaccine study

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
Published: 2022-06-29 (Crawled : 21:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| -6.98% | O: 1.06% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -48.8% | O: 1.79% H: 2.31% C: 1.43%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -11.94% | O: -4.58% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -38.86% | O: 3.2% H: 4.97% C: 1.76%
covid-19 vaccine agreement

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Published: 2022-06-25 (Crawled : 16:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| Email alert Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 -20.84% 320

|

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| Email alert Add to watchlist
covid-19 vaccine response

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
Published: 2022-06-17 (Crawled : 14:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| -4.95% | O: -4.49% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -4.59% | O: -1.76% H: 5.75% C: 5.5%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -45.64% | O: -0.74% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -4.68% | O: 1.39% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -32.78% | O: 0.78% H: 0.0% C: 0.0%
covid-19 fda children vaccine authorization emergency use authorization

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Published: 2022-05-23 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -17.6% | O: -3.11% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -49.28% | O: 2.55% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -14.4% | O: 1.61% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -48.27% | O: -0.85% H: 0.06% C: -1.91%
covid-19 children vaccine

The ¡Ándale! ¿Qué Esperas? Campaign, Grupo Chespirito join to Celebrate El Día Del Niño and Raise Awareness of the Benefits of the Covid-19 Vaccine through PSA's Featuring the Beloved Character, El Chavo
Published: 2022-04-29 (Crawled : 17:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| Email alert Add to watchlist
covid-19 vaccine benefits

Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
Published: 2022-04-14 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -15.54% | O: 3.34% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -17.95% | O: -1.56% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -51.61% | O: -0.67% H: 1.98% C: -1.62%
covid-19 children vaccine response

Pangea Laboratory Donates 50,000 COVID-19 PCR Tests for the Uninsured
Published: 2022-04-06 (Crawled : 14:20) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320

|

| Email alert Add to watchlist
covid-19 test

Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -51.2% | O: 1.35% H: 0.15% C: -2.33%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -9.9% | O: -0.12% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -47.81% | O: 1.83% H: 3.58% C: 1.77%
covid-19 authorization vaccine order emergency use authorization

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -50.2% | O: 0.56% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -9.99% | O: 0.82% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M

|

Health Technology

| -40.15% | O: 1.63% H: 11.55% C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization

← Previous
1
2
Next →

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Your saved searches

Save your searches and get alerts when important news are released.